Ercros, S.A. (LON:0M0E)

London · Delayed Price · Currency is GBP · Price in EUR

3.500

+0.002 (0.07%)

At close: Sep 2, 2026

27.97% (1Y)

Market Cap	273.89M +26.8%
Revenue (ttm)	547.68M -2.9%
Net Income	-24.31M
EPS	-0.27
Shares Out	n/a
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	8
Open	3.490
Previous Close	3.498
Day's Range	3.500 - 3.500
52-Week Range	2.240 - 3.500
Beta	0.19
Analysts	n/a
Price Target	n/a
Earnings Date	Nov 6, 2026

About Ercros

Ercros, S.A., together with its subsidiaries, manufactures and sells chemical and pharmaceutical products in Spain and internationally. It operates through three segments: Chlorine Derivatives, Intermediate Chemicals, and Pharmaceuticals. The company offers ammonia, caustic soda and potash, chlorine chloroisocyanurates, dichloroethane, ercrosbio, hydrochloric acid, hydrogen peroxide, polyvinyl chloride, potassium carbonate, PVC compounds, sodium chlorate, sodium chlorite, sodium hypochlorite, sulfuric acid, and vinyl chloride. It also provides ... [Read more]

Industry Industrial Inorganic Chemicals

Founded 1817

Employees 1,346

Stock Exchange London Stock Exchange

Ticker Symbol 0M0E

Financial Performance

In 2025, Ercros's revenue was 628.69 million, a decrease of -5.92% compared to the previous year's 668.22 million. Losses were -53.59 million, 359.7% more than in 2024.

Financial numbers in EUR Financial Statements